Free Cash Flow

With a key drug for a rare disease nearing the finish line, Spruce adds two industry veterans to navigate the high-stakes FDA approval process.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

As CFO Mike Santomassimo prepares for the UBS conference, investors seek clarity on Wells Fargo's strategy after its asset cap removal and rate cut impacts.

An independent analysis shows a specialized OB/GYN staffing model improves maternal outcomes, lowers C-section rates, and delivers a significant return on investment.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

The Swedish industrial giant posted strong sales and improved margins for 2025, but a significant dip in new orders has investors watching the future closely.

Pharming Group projects strong 2026 growth, fueling ambitious clinical programs for rare immunodeficiencies and mitochondrial diseases.

After orchestrating a major divestiture, Stoneridge's long-time CFO Matt Horvath resigns, ushering in a new era for the transportation tech firm.

CEO Andy Silvernail will detail the packaging giant's split and future strategy amid mixed earnings, setting high stakes for his upcoming investor address.

Liberty Energy seeks $500M in convertible notes, a complex financial move to repay debt, fund its diversification, and manage shareholder dilution.

Celanese completes a key divestiture to tackle its massive debt, while buyer Element Solutions bolsters its high-growth electronics portfolio.

Morningstar's $365M CRSP acquisition and extended Vanguard pact positions it to challenge index titans, promising a new era for low-cost investing.

Atlantic International hires veteran CFO Kevin J. Murphy to integrate its massive Circle8 acquisition and navigate a complex financial landscape.

With home health aide costs nearing $78,000 annually, families face a financial maze. Learn key strategies for creating a realistic budget for senior care.

Smashing its target, Hamilton Lane's new fund highlights intense investor appetite for assets powering AI, logistics, and the energy transition.

The analytics giant pays down debt and buys back stock, signaling financial health, but faces analyst skepticism over its long-term growth strategy.

Hyperscale Data reaffirms its $100M Bitcoin plan to fund its AI data center, defying a 95% stock drop and major financial red flags. Is it genius or folly?

Facing default, The Cannabist Company secures a short-term forbearance, highlighting a systemic liquidity crisis threatening the US cannabis industry.

The oil & gas operator is one step from a NYSE listing, promising a 13.5% dividend yield and a major consolidation play in the mature assets market.

Flowco's steady dividend signals financial health in a volatile sector, but its strategic focus on methane abatement technology is the real growth story.